Social adjustment and family function after drug switch from IR-methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder

References

• PolanczykGde LimaMSHortaBLBiedermanJRohdeLAThe worldwide prevalence of ADHD: a systematic review and metaregression analysisAm J Psychiatry2007164694294817541055
   PubMed Web of Science ®Google Scholar
• PolanczykGVWillcuttEGSalumGAKielingCRohdeLAADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysisInt J Epidemiol201443243444224464188
   PubMed Web of Science ®Google Scholar
• GauSSChongMYChenTHChengATA 3-year panel study of mental disorders among adolescents in TaiwanAm J Psychiatry200516271344135015994718
   PubMed Web of Science ®Google Scholar
• FeldmanHMReiffMIClinical practice. Attention deficit-hyperactivity disorder in children and adolescentsN Engl J Med2014370983884624571756
   PubMed Web of Science ®Google Scholar
• TarverJDaleyDSayalKAttention-deficit hyperactivity disorder (ADHD): an updated review of the essential factsChild Care Health Dev201440676277424725022
   PubMed Web of Science ®Google Scholar
• CountsCANiggJTStawickiJARappleyMDvon EyeAFamily adversity in DSM-IV ADHD combined and inattentive subtypes and associated disruptive behavior problemsJ Am Acad Child Adolesc Psychiatry200544769069815968238
   PubMed Web of Science ®Google Scholar
• HeathCLCurtisDFFanWMcphersonRThe association between parenting stress, parenting self-efficacy, and the clinical significance of child ADHD symptom change following behavior therapyChild Psychiatry Hum Dev201546111812924668566
   PubMed Web of Science ®Google Scholar
• DeaultLCA systematic review of parenting in relation to the development of comorbidities and functional impairments in children with attention-deficit/hyperactivity disorder (ADHD)Child Psychiatry Hum Dev201041216819219768532
   PubMed Web of Science ®Google Scholar
• Hernández-OteroIDoddamaniLDutrayBStress levels experienced by parents of children with and without attention-deficit/hyperactivity disorder during the back-to-school period: results of a European and Canadian surveyInt J Psychiatry Clin Pract201519181725195767
   PubMed Web of Science ®Google Scholar
• FindlingRLEvolution of the treatment of attention-deficit/hyperactivity disorder in children: a reviewClin Ther200830594295718555941
   PubMed Web of Science ®Google Scholar
• GauSSChenSJChouWJNational survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in TaiwanJ Clin Psychiatry200869113114018312048
   PubMed Web of Science ®Google Scholar
• KatzmanMASternatTA review of OROS methylphenidate (Concerta(®)) in the treatment of attention-deficit/hyperactivity disorderCNS Drugs201428111005103325120227
   PubMed Web of Science ®Google Scholar
• PunjaSZorzelaLHartlingLUrichukLVohraSLong-acting versus short-acting methylphenidate for paediatric ADHD: a systematic review and meta-analysis of comparative efficacyBMJ Open201333e002312
   PubMed Web of Science ®Google Scholar
• SchawoSvan der KolkABouwmansCProbabilistic Markov model estimating cost effectiveness of methylphenidate osmotic-release oral system versus immediate-release methylphenidate in children and adolescents: which information is needed?Pharmacoeconomics201533548950925715975
   PubMed Web of Science ®Google Scholar
• van der SchansJKotsopoulosNHoekstraPJHakEPostmaMJCost-effectiveness of extended-release methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder sub-optimally treated with immediate release methylphenidatePLoS One2015105e012723726024479
   PubMed Web of Science ®Google Scholar
• KimBNKimYNCheongUSSwitching from methylphenidate-immediate release (MPH-IR) to methylphenidate-OROS (OROS-MPH): a multi-center, open-label study in KoreaClin Psychopharmacol Neurosci201191293523430964
   PubMedGoogle Scholar
• RemschmidtHHoarePEttrichCSymptom control in children and adolescents with attention-deficit/hyperactivity disorder on switching from immediate-release MPH to OROS MPH Results of a 3-week open-label studyEur Child Adolesc Psychiatry200514629730416220213
   PubMed Web of Science ®Google Scholar
• ChouWJChouMCTzangRFBetter efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypesPsychiatry Clin Neurosci200963216717519335386
   PubMed Web of Science ®Google Scholar
• Ramos-QuirogaJABoschRCastellsXEffect of switching drug formulations from immediate-release to extended-release OROS methylphenidate: a chart review of Spanish adults with attention-deficit hyperactivity disorderCNS Drugs200822760361118547128
   PubMed Web of Science ®Google Scholar
• KimYShinMSKimJWYooHJChoSCKimBNNeurocognitive effects of switching from methylphenidate-IR to OROS-methylphenidate in children with ADHDHum Psychopharmacol20092429510219226534
   PubMed Web of Science ®Google Scholar
• KordonAStollhoffKNiederkirchnerKMattejatFRettigKSchäubleBExploring the impact of once-daily OROS® methylphenidate (MPH) on symptoms and quality of life in children and adolescents with ADHD transitioning from immediate-release MPHPostgrad Med201112352738
   PubMed Web of Science ®Google Scholar
• ChouWJChenSJChenYSRemission in children and adolescents diagnosed with attention-deficit/hyperactivity disorder via an effective and tolerable titration scheme for osmotic release oral system methylphenidateJ Child Adolesc Psychopharmacol201222321522522537358
   PubMed Web of Science ®Google Scholar
• TzangRFWangYCYehCBNaturalistic exploration of the effect of osmotic release oral system-methylphenidate on remission rate and functional improvement in Taiwanese children with attention-deficit-hyperactivity disorderPsychiatry Clin Neurosci2012661536322250610
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders4th edWashington, DCAmerican Psychiatric Association2000
   Google Scholar
• BussingRFernandezMHarwoodMParent and teacher SNAP-IV ratings of attention deficit hyperactivity disorder symptoms: psychometric properties and normative ratings from a school district sampleAssessment200815331732818310593
   PubMed Web of Science ®Google Scholar
• GauSSLinCHHuFCPsychometric properties of the Chinese version of the Swanson, Nolan, and Pelham, Version IV Scale-Teacher FormJ Pediatr Psychol200934885086119074488
   PubMed Web of Science ®Google Scholar
• GauSSShangCYLiuSKPsychometric properties of the Chinese version of the Swanson, Nolan, and Pelham, version IV scale – parent formInt J Methods Psychiatr Res2008171354418286459
   PubMed Web of Science ®Google Scholar
• JohnKGammonGDPrusoffBAWarnerVThe Social Adjustment Inventory for Children and Adolescents (SAICA): testing of a new semi-structured interviewJ Am Acad Child Adolesc Psychiatry19872668989113429410
   PubMed Web of Science ®Google Scholar
• GauSSShenHYChouMCTangCSChiuYNGauCSDeterminants of adherence to methylphenidate and the impact of poor adherence on maternal and family measuresJ Child Adolesc Psychopharmacol200616328629716768636
   PubMed Web of Science ®Google Scholar
• GauSSParental and family factors for attention-deficit hyperactivity disorder in Taiwanese childrenAust N Z J Psychiatry200741868869617620166
   PubMed Web of Science ®Google Scholar
• GuyWECDEU Assessment Manual for Psychopharmacology Revised 1976MarylandUS Department of Health, Education, and Welfare
   Google Scholar
• GoldbergDPGaterRSartoriusNThe validity of two versions of the GHQ in the WHO study of mental illness in general health carePsychol Med19972711911979122299
   PubMed Web of Science ®Google Scholar
• ChengTAWilliamsPThe design and development of a screening questionnaire (CHQ) for use in community studies of mental disorders in TaiwanPsychol Med19861624154223726013
   PubMed Web of Science ®Google Scholar
• SmilksteinGAshworthCMontanoDValidity and reliability of the family APGAR as a test of family functionJ Fam Pract19821523033117097168
   PubMed Web of Science ®Google Scholar
• ChauTTHsiaoTMHuangCTLiuHW家庭關懷度指數的初步研究 [A preliminary study of family Apgar index in the Chinese]Gaoxiong Yi Xue Ke Xue Za Zhi1991712731 Chinese1990150
   PubMedGoogle Scholar
• GormezVAveryBMannHSwitching from immediate release to sustained release methylphenidate in the treatment of children and adolescents with attention deficit/hyperactivity disorderEur Rev Med Pharmacol Sci201317172345234924065228
   PubMed Web of Science ®Google Scholar
• SteeleMWeissMSwansonJWangJPrinzoRSBinderCEA randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorderCan J Clin Pharmacol2006131e50e6216456216
   PubMedGoogle Scholar
• KimJWParkSKimBNParental perceived benefits of OROS-methylphenidate treatment for the child with attention-deficit/hyperactivity disorder and for parents themselvesPharmacopsychiatry201346413714623364873
   PubMed Web of Science ®Google Scholar
• AhmedRMcCafferyKJAslaniPFactors influencing parental decision making about stimulant treatment for attention-deficit/hyperactivity disorderJ Child Adolesc Psychopharmacol201323316317823560602
   PubMed Web of Science ®Google Scholar
• GajriaKLuMSikiricaVAdherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature reviewNeuropsychiatr Dis Treat2014101543156925187718
   PubMed Web of Science ®Google Scholar